Of the 9 cancers shortlisted in the pan-cancer analysis based on CTHRC1 overexpression and its effect on cancer survival (Fig 3A–3C), BRCA, HNSC and LIHC were also shortlisted in the individual cancer study based on their CTHRC1 expression and its effect on survival. Here, CTHRC1 is linked to cancer.